These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 387223)

  • 1. Toxic effects of cis-dichlorodiammineplatinum(II) in man.
    Von Hoff DD; Schilsky R; Reichert CM; Reddick RL; Rozencweig M; Young RC; Muggia FM
    Cancer Treat Rep; 1979; 63(9-10):1527-31. PubMed ID: 387223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
    Rossof AH; Coltman CA; Jones SE; Talley RW
    Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
    Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
    Vietti TJ; Nitschke R; Starling KA; van Eys J
    Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.
    Casper ES; Gralla RJ; Kelsen DP; Cvitkovic E; Golbey RB
    Cancer Treat Rep; 1979; 63(11-12):2107-9. PubMed ID: 575068
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cis-dichlorodiammineplatinum, a representative of a new group of cytostatic drugs].
    Janas J
    Nowotwory; 1981; 31(3-4):251-6. PubMed ID: 7045812
    [No Abstract]   [Full Text] [Related]  

  • 7. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.
    Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ
    Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxic effects of cisplatin in the treatment of malignant bone and soft tissue tumors].
    Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1857-61. PubMed ID: 3707148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.
    Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH
    Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II.
    Calvert AH; Harland SJ; Newell DR; Siddik ZH; Jones AC; McElwain TJ; Raju S; Wiltshaw E; Smith IE; Baker JM; Peckham MJ; Harrap KR
    Cancer Chemother Pharmacol; 1982; 9(3):140-7. PubMed ID: 6761010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck.
    Wittes RE; Cvitkovic E; Shah J; Gerold FP; Strong EW
    Cancer Treat Rep; 1977; 61(3):359-66. PubMed ID: 872136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of anguidine administered weekly.
    Belt RJ; Haas CD; Joseph U; Goodwin W; Moore D; Hoogstraten B
    Cancer Treat Rep; 1979; 63(11-12):1993-5. PubMed ID: 526932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mannitol or furosemide diuresis on cis-dichlorodiammineplatinum(II) antitumor activity and toxicity to host-renewing cell populations in rats.
    Pera MF; Harder HC
    Cancer Res; 1979 Apr; 39(4):1279-86. PubMed ID: 421211
    [No Abstract]   [Full Text] [Related]  

  • 15. Cis-dichlorodiammineplatinum(II) in advanced soft tissue and bony sarcomas: a Southwest Oncology Group Study.
    Samson MK; Baker LH; Benjamin RS; Lane M; Plager C
    Cancer Treat Rep; 1979; 63(11-12):2027-9. PubMed ID: 575067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
    Kamalakar P; Freeman AI; Higby DJ; Wallace HJ; Sinks LF
    Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
    Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
    Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group].
    Taguchi T; Wakui A; Nabeya K; Kurihara M; Isono K; Kakegawa T; Ota K
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):483-8. PubMed ID: 1558398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.
    Evans BD; Raju KS; Calvert AH; Harland SJ; Wiltshaw E
    Cancer Treat Rep; 1983 Nov; 67(11):997-1000. PubMed ID: 6315233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [About side effects of platinum drugs].
    Waszkiewicz K
    Postepy Hig Med Dosw; 2001; 55(3):387-406. PubMed ID: 11505639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.